LHYFE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.03 EUR | +1.00% |
|
+1.26% | -20.04% |
| Jun. 24 | Lhyfe: up to 11 ME subsidy for green hydrogen | CF |
| Jun. 19 | Lhyfe: first production site in Germany | CF |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 414.2 | 241.3 | 191.1 | - | - |
| Enterprise Value (EV) 1 | 292 | 241.3 | 206.5 | 291.7 | 358.7 |
| P/E ratio | -12.4 x | -7.2 x | -4.93 x | -4.66 x | -15.1 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 727 x | 183 x | 16.3 x | 4.99 x | 1.97 x |
| EV / Revenue | 512 x | 183 x | 17.7 x | 7.62 x | 3.69 x |
| EV / EBITDA | -17.2 x | -8.59 x | -6.85 x | -12.2 x | 72.5 x |
| EV / FCF | -11 x | -4.35 x | -2.17 x | -2.68 x | -5.35 x |
| FCF Yield | -9.1% | -23% | -46% | -37.3% | -18.7% |
| Price to Book | 2.39 x | - | 2.87 x | 6.05 x | 9.28 x |
| Nbr of stocks (in thousands) | 47,879 | 47,868 | 47,891 | - | - |
| Reference price 2 | 8.650 | 5.040 | 3.990 | 3.990 | 3.990 |
| Announcement Date | 3/22/23 | 3/28/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 0.57 | 1.317 | 11.7 | 38.27 | 97.1 |
| EBITDA 1 | - | -17 | -28.1 | -30.13 | -23.87 | 4.95 |
| EBIT 1 | - | -18.16 | -33.97 | -37.47 | -35.63 | -5.25 |
| Operating Margin | - | -3,185.09% | -2,579.65% | -320.23% | -93.12% | -5.41% |
| Earnings before Tax (EBT) 1 | - | -25.81 | -32.75 | -41.4 | -45.4 | -15.3 |
| Net income 1 | -8.724 | -25.82 | -33.49 | -39.6 | -41.8 | -13.3 |
| Net margin | - | -4,529.65% | -2,542.75% | -338.46% | -109.23% | -13.7% |
| EPS 2 | -0.4500 | -0.7000 | -0.7000 | -0.8100 | -0.8567 | -0.2650 |
| Free Cash Flow 1 | - | -26.57 | -55.46 | -95.1 | -108.9 | -67 |
| FCF margin | - | -4,661.05% | -4,211.01% | -812.82% | -284.58% | -69% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/22/22 | 3/22/23 | 3/28/24 | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 15.5 | 101 | 168 |
| Net Cash position 1 | - | 122 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.5127 x | -4.217 x | 33.86 x |
| Free Cash Flow 1 | - | -26.6 | -55.5 | -95.1 | -109 | -67 |
| ROE (net income / shareholders' equity) | - | -40.5% | - | -42.7% | -70.5% | -43% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 3.620 | - | 1.390 | 0.6600 | 0.4300 |
| Cash Flow per Share 2 | - | -0.4100 | - | -0.7000 | -0.5000 | - |
| Capex 1 | - | 11.5 | - | 45.7 | 47.3 | 51.6 |
| Capex / Sales | - | 2,019.82% | - | 390.6% | 123.61% | 53.14% |
| Announcement Date | 4/22/22 | 3/22/23 | 3/28/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.99
EUR
Average target price
5.267
EUR
Spread / Average Target
+32.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.24% | 206M | |
| +18.26% | 148B | |
| +10.84% | 84.98B | |
| -0.25% | 83.47B | |
| +2.89% | 77.05B | |
| -0.92% | 72.78B | |
| +79.72% | 66.22B | |
| 0.00% | 47.33B | |
| +7.81% | 46.15B | |
| +4.70% | 41.25B |
- Stock Market
- Equities
- LHYFE Stock
- Financials Lhyfe
